Odyssey Group International, Inc. (ODYY)
USD 0.01
(-3.28%)
USD 0.01
(-3.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.1 Million USD | 44.43% |
| 2022 | 1.45 Million USD | 712.33% |
| 2021 | 179.65 Thousand USD | -15.66% |
| 2020 | 213.02 Thousand USD | -65.52% |
| 2019 | 617.81 Thousand USD | -2.13% |
| 2018 | 631.25 Thousand USD | 50.43% |
| 2017 | 419.62 Thousand USD | 123.21% |
| 2016 | 187.99 Thousand USD | 1396.07% |
| 2015 | 12.56 Thousand USD | -93.51% |
| 2014 | 193.6 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.31 Million USD | -38.72% |
| 2024 Q3 | 1.53 Million USD | 16.34% |
| 2024 Q1 | 2.15 Million USD | 2.12% |
| 2023 FY | 2.1 Million USD | 44.43% |
| 2023 Q4 | 2.1 Million USD | 10.85% |
| 2023 Q3 | 1.9 Million USD | 5.49% |
| 2023 Q1 | 1.57 Million USD | 8.23% |
| 2023 Q2 | 1.8 Million USD | 14.12% |
| 2022 Q3 | 1.29 Million USD | 1.0% |
| 2022 Q2 | 1.28 Million USD | 98.83% |
| 2022 Q1 | 644.77 Thousand USD | 258.89% |
| 2022 FY | 1.45 Million USD | 712.33% |
| 2022 Q4 | 1.45 Million USD | 12.71% |
| 2021 Q2 | 348.25 Thousand USD | 12627.23% |
| 2021 Q3 | -702.37 Thousand USD | -301.68% |
| 2021 Q4 | 179.65 Thousand USD | 125.58% |
| 2021 Q1 | -2780.00 USD | -101.31% |
| 2021 FY | 179.65 Thousand USD | -15.66% |
| 2020 FY | 213.02 Thousand USD | -65.52% |
| 2020 Q1 | 791.05 Thousand USD | 28.04% |
| 2020 Q4 | 213.02 Thousand USD | -80.65% |
| 2020 Q3 | 1.1 Million USD | 11.0% |
| 2020 Q2 | 991.8 Thousand USD | 25.38% |
| 2019 Q2 | 667.25 Thousand USD | -0.67% |
| 2019 Q4 | 617.81 Thousand USD | -13.49% |
| 2019 Q3 | 714.18 Thousand USD | 7.03% |
| 2019 FY | 617.81 Thousand USD | -2.13% |
| 2019 Q1 | 671.73 Thousand USD | 6.41% |
| 2018 FY | 631.25 Thousand USD | 50.43% |
| 2018 Q1 | 488.42 Thousand USD | 16.4% |
| 2018 Q2 | 565.28 Thousand USD | 15.74% |
| 2018 Q3 | 597.71 Thousand USD | 5.74% |
| 2018 Q4 | 631.25 Thousand USD | 5.61% |
| 2017 Q4 | 419.62 Thousand USD | 36.65% |
| 2017 FY | 419.62 Thousand USD | 123.21% |
| 2017 Q3 | 307.08 Thousand USD | 43.61% |
| 2017 Q2 | 213.83 Thousand USD | 9.36% |
| 2017 Q1 | 195.52 Thousand USD | 4.01% |
| 2016 FY | 187.99 Thousand USD | 1396.07% |
| 2016 Q1 | 32.43 Thousand USD | 158.11% |
| 2016 Q4 | 187.99 Thousand USD | 10.95% |
| 2016 Q3 | 169.43 Thousand USD | 80.73% |
| 2016 Q2 | 93.75 Thousand USD | 189.06% |
| 2015 FY | 12.56 Thousand USD | -93.51% |
| 2015 Q4 | 12.56 Thousand USD | 8.98% |
| 2015 Q1 | 75.66 Thousand USD | 0.0% |
| 2015 Q3 | 11.53 Thousand USD | -28.99% |
| 2015 Q2 | 16.23 Thousand USD | -78.54% |
| 2014 FY | 193.6 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| IR-Med Inc. | -606 Thousand USD | 447.821% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 85.784% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -873.092% |
| Polarean Imaging plc | -5.94 Million USD | 135.446% |
| Avitar, Inc. | 5.17 Million USD | 59.239% |
| AVITA Medical, Inc. | -26.23 Million USD | 108.035% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 30211.357% |
| Össur hf. | 395.08 Million USD | 99.466% |
| Zecotek Photonics Inc. | 2.76 Million USD | 23.698% |
| QHSLab, Inc. | 1.72 Million USD | -21.84% |
| Wellstar International, Inc. | 51.36 Million USD | 95.897% |
| Össur hf. | 395.08 Million USD | 99.466% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 145.651% |
| Escalon Medical Corp. | 315.68 Thousand USD | -567.687% |
| Aurora Spine Corporation | 1.9 Million USD | -10.491% |
| BrainsWay Ltd. | -10.32 Million USD | 120.424% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 12.722% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 88.371% |
| Vivos Inc. | -1.59 Million USD | 232.375% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.687% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -332.516% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 489.621% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -229.242% |
| Nanomix Corporation | 11.38 Million USD | 81.493% |
| Theraclion SA | -5.86 Million EUR | 135.941% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 47.113% |
| Positron Corporation | 1.68 Million USD | -24.952% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -30.851% |
| Lombard Medical, Inc. | 11.49 Million USD | 81.663% |
| ALR Technologies Inc. | 19.14 Million USD | 88.992% |
| Stratec SE | 119.12 Million USD | 98.231% |
| Vycor Medical, Inc. | 1.05 Million USD | -100.179% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -3732.703% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -2161.728% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 115.288% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 93.008% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1578536.159% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -43.681% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -234.083% |
| United American Healthcare Corporation | -9.32 Million USD | 122.599% |
| ECGI Holdings, Inc. | 3.17 Million USD | 33.534% |
| Capital Group Holdings, Inc. | -3508.00 USD | 60185.376% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -702.609% |
| Urologix, Inc. | 4.61 Million USD | 54.327% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 49.927% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 36.727% |
| SS Innovations International, Inc. | 1.18 Million USD | -77.821% |
| Qualis Innovations, Inc. | 6671.00 USD | -31496.387% |
| Smith & Nephew plc | 2.77 Billion USD | 99.924% |
| NIOX Group Plc | -23.93 Million USD | 108.807% |
| Fuse Medical, Inc. | 1.75 Million USD | -20.068% |
| Broncus Holding Corporation | -81.42 Million USD | 102.589% |
| Brain Scientific Inc. | 2.11 Million USD | 0.377% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 90.705% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -5228.501% |